A mass rollout of weight loss injections begins across the NHS on Monday, with GPs able to prescribe Mounjaro for the first time. The drug, also known as tirzepatide and manufactured by Lilly, is an antidiabetic medication that works by lowering blood sugar levels and slowing down the digestion of food.

Around 220,000 people with "greatest need" are expected to receive Mounjaro, also known as tirzepatide and made by Lilly through the NHS over the next three years

GPs in England will be able to prescribe weight loss jabs for the first time on the NHS on Monday, as the health service begins its mass rollout. Some 220,000 people with the “greatest need” are expected to receive Mounjaro,